Saturday, 24 July 2021

Abdominal Aortic Aneurysm (AAA) – Market outlook, Epidemiology, Market Forecast and Competitive Landscape Report – 2020 To 2030


 

Indication name: Abdominal Aortic Aneurysm (AAA)

Abdominal Aortic Aneurysm (AAA) – Market outlook, Epidemiology, Market Forecast and Competitive Landscape Report – 2020 To 2030 (Markets covered: US, Germany, France, Spain, United Kingdom, Italy, Japan & China).

An abdominal aortic aneurysm (AAA) is an enlarged area in the lower part of the major vessel that supplies blood to the body (aorta). The aorta runs from your heart through the center of the chest and abdomen. The prognosis of the disease is poor, following the rupture of an abdominal aortic aneurysm, the risk of death is approximately 80%. Most patients die before reaching the hospital. In most patients, the outcome is poor and surgical repair is only successful in 50% of cases with a ruptured aneurysm.


Epidemiology-

The annual incidence of new AAA diagnoses is approximately 0.4 to 0.67 percent in Western populations. This equates to 2.5 to 6.5 aneurysms per 1000 person-years. Age significantly impacts the incidence. As an example, in one study, among men aged 65 to 74 years, the incidence was 55 per 100,000 person-years, increasing to 112 per 100,000 person-years for men aged 75 to 85 years, this further increased to 298 per 100,000 person-years for those older than 85.

The market is expected to show a very strong growth throughout the study period (2020 - 2030), growing at a CAGR of ~7.6%. Major drivers of the growth are the newer pharmacotherapies which are expected to launch the market in the near future.


Competitive landscape of Abdominal Aortic Aneurysm (AAA) includes country specific approved as well as pipeline therapies. Any asset/ product specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary.

Abdominal Aortic Aneurysm (AAA) Market Forecast:
Patient Based Forecast Model (MS. Excel Based Automated Dashboard) which Data Inputs with sourcing, Market Event and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden and pricing scenario, Summary and Insights.

KOLs insights of Abdominal Aortic Aneurysm (AAA) across 8 MM market from center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm and Unmet needs.

Read more:
Abdominal Aortic Aneurysm (AAA) – Market outlook, Epidemiology, Market Forecast and Competitive Landscape Report – 2020 To 2030

S. No                Asset                Company                      Stage
1                      Alirocumab Regeneron Pharmaceuticals Phase 3
2          Metformin Glucophage 500mg (IR) tablets M90 Merck Serono GmbH, Germany Phase 3
3          Ticagrelor AstraZeneca Phase 2 1

No comments:

Post a Comment

Post-traumatic stress disorder (PTSD) – Market outlook, Epidemiology, Market Forecast and Competitive Landscape Report – 2020 To 2030

  Indication name: Post-traumatic stress disorder (PTSD) Post-traumatic stress disorder (PTSD) – Market outlook, Epidemiology, Market For...